vTv Therapeutics Announces Positive Study Results of Potential First-in-Class Oral Adjunctive Therapy for T1D

On February 10, vTv Therapeutics announced positive study results from the second part of the Phase 2 Simplici-T1 Study of TTP399.

New Evidence Shows Vital Importance of Screening For T1D in Children

By screening for Type 1 diabetes in children, Bavaria was able to decrease rates of diabetic ketoacidosis at diagnosis.

Implanted PEC-01 Cells Capable of Producing Insulin According to New Data Presented from ViaCyte

ViaCyte presented preliminary data from their PEC-Direct trial, showing that PEC-01 cells are capable of producing insulin in patients with Type 1 diabetes.

Clinical Trials and the Type 1 Diabetes Cure

I think the ultimate cure for T1D will be prevention. Why can’t we screen and predict who is at risk, and then prevent someone from getting Type 1 diabetes in the first place? How do clinical trials help?

The Human Trial and What it Means for a Cure

Looking for heroism in the forgotten corners of our globe and from those least likely to claim the spotlight, Lisa turns her eye to the stem cell research (regenerative medicine) being done by Viacyte — a biotech company based out of San Diego that is currently undergoing clinical trails, implanting healthy beta cells into a human pancreas.